Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bucher

Showing results (361-370 of 406) with videos related to

Pageof 41
Sort By:
Antimicrobial Resistance and Infection Control|July 29, 2023
Best practice guidance for antibiotic audit and feedback interventions in primary care: a modified Delphi study from the Joint Programming Initiative on Antimicrobial resistance: Primary Care Antibiotic Audit and Feedback Network (JPIAMR-PAAN)Kevin L Schwartz, Alice X T Xu, Sarah Alderson, et al.
JAMA|November 3, 2005
Randomized trials stopped early for benefit: a systematic reviewVictor M Montori, P J Devereaux, Neill K J Adhikari, et al.
Open Forum Infectious Diseases|April 10, 2023
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
AIDS (London, England)|May 2, 2012
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational studyLauren E Cain, Andrew Phillips, Sara Lodi, et al.
AIDS (London, England)|September 23, 2009
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals, Maile Ray, Roger Logan, et al.
The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.
Open Forum Infectious Diseases|November 29, 2023
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
Family Practice|October 6, 2021
Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care. A randomized controlled trial secondary analysis in 15 European countriesDan Ouchi, Ana García-Sangenís, Ana Moragas, et al.
American Journal of Epidemiology|May 8, 2019
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With ApplesSara Lodi, Andrew Phillips, Jens Lundgren, et al.
The Journal of Infectious Diseases|June 7, 2024
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 StudyAlain Amstutz, Frédérique Chammartin, Annette Audigé, et al.
Pageof 41

Showing results (361-370 of 406) with videos related to

Sort By:
Pageof 41
Antimicrobial Resistance and Infection Control|July 29, 2023
Best practice guidance for antibiotic audit and feedback interventions in primary care: a modified Delphi study from the Joint Programming Initiative on Antimicrobial resistance: Primary Care Antibiotic Audit and Feedback Network (JPIAMR-PAAN)Kevin L Schwartz, Alice X T Xu, Sarah Alderson, et al.
JAMA|November 3, 2005
Randomized trials stopped early for benefit: a systematic reviewVictor M Montori, P J Devereaux, Neill K J Adhikari, et al.
Open Forum Infectious Diseases|April 10, 2023
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
AIDS (London, England)|May 2, 2012
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational studyLauren E Cain, Andrew Phillips, Sara Lodi, et al.
AIDS (London, England)|September 23, 2009
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals, Maile Ray, Roger Logan, et al.
The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.
Open Forum Infectious Diseases|November 29, 2023
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
Family Practice|October 6, 2021
Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care. A randomized controlled trial secondary analysis in 15 European countriesDan Ouchi, Ana García-Sangenís, Ana Moragas, et al.
American Journal of Epidemiology|May 8, 2019
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With ApplesSara Lodi, Andrew Phillips, Jens Lundgren, et al.
The Journal of Infectious Diseases|June 7, 2024
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 StudyAlain Amstutz, Frédérique Chammartin, Annette Audigé, et al.
Pageof 41